CRISPR/Cas mediated genome editing in medicinal plants
Publish Year: 1399
Type: Conference paper
Language: English
View: 412
This Paper With 11 Page And PDF Format Ready To Download
- Certificate
- I'm the author of the paper
Export:
Document National Code:
MPSA11_049
Index date: 13 April 2021
CRISPR/Cas mediated genome editing in medicinal plants abstract
The safe application of the organic materials leads to more popularity of plant-derived medicines in the recent years. For a long time, classical biotechnology techniques have been exploited in order to obtain a multitude of beneficial traits like, from unraveling the entire metabolic pathwayto increased metabolite and nutrient production, etc. However, conventional genetic engineering methods are not suitable for adding large-concerted changes into a plant, because the random insertion of DNA construct into one or more loci in one or more chromosomes can lead toundesirable effects. The CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system was first identified in bacteria and archaea and candegrade exogenous substrates. Therefore, CRISPR/Cas is considered a revolutionary technology in plant biology. Here, we introduce the mechanism of the CRISPR/Cas in particular CRISPR/Cas9, update its recent advances in various applications in plants, and discuss its future prospects to provide an argument for its use in the study of medicinal plants.
CRISPR/Cas mediated genome editing in medicinal plants Keywords:
CRISPR/Cas mediated genome editing in medicinal plants authors
Rahim Ghezzi
Master student in plant genetics and breeding
Leila Nejad Sadeghi
Assistant Professor, Department of Plant Production Engineering and Genetics, Faculty of Agriculture, Shahid Chamran University of Ahvaz.